AIMD: מקדם מחיר להכנסות Ainos Corp

Ainos, Inc. relies on patents in the fields of AI respiratory diagnostics and portable testing. The company's P/S ratio helps track market value dynamics relative to revenue, with the 779.00 level representing the current value. The business adheres to bioethics and ESG standards. Growth depends on FDA certification and the scaling of capacities in the US and Taiwan.

Ainos, Inc. optimizes medical logistics through express diagnostics, which directly impacts revenue scalability. The P/S ratio measures the market value of each unit of these sales, allowing for an assessment of the premium paid for future growth. A decline in this metric signals that assets are undervalued relative to their operating turnover. The price/sales trend helps identify entry points, eliminating the risk of purchasing an asset at the peak of market optimism.